Search Results

There are 851 results for: content related to: AUSTRALIA'S EXPERIENCE WITH VARENICLINE: USAGE, COSTS AND ADVERSE REACTIONS

  1. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe and Tim Lancaster

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD006103.pub7

  2. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  3. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Version of Record online : 20 NOV 2013, DOI: 10.1111/adb.12108

  4. Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In VitroIn Vivo Study

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 567–576, B Feng, RS Obach, AH Burstein, DJ Clark, SM de Morais and HM Faessel

    Version of Record online : 31 OCT 2007, DOI: 10.1038/sj.clpt.6100405

  5. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12588

  6. Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings

    Alcoholism: Clinical and Experimental Research

    Volume 40, Issue 7, July 2016, Pages: 1567–1576, Terril L. Verplaetse, Brian P. Pittman, Julia M. Shi, Jeanette M. Tetrault, Sabrina Coppola and Sherry A. McKee

    Version of Record online : 1 JUN 2016, DOI: 10.1111/acer.13110

  7. The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative-Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 12, December 2010, Pages: 2053–2060, Helen M. Kamens, Jimena Andersen and Marina R. Picciotto

    Version of Record online : 14 OCT 2010, DOI: 10.1111/j.1530-0277.2010.01301.x

  8. You have free access to this content
    Interventions for smoking cessation and reduction in individuals with schizophrenia

    Intervention Review

    The Cochrane Library

    Daniel T Tsoi, Mamta Porwal and Angela C Webster

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD007253.pub3

  9. Clinical experience of varenicline for smoking cessation

    The Clinical Respiratory Journal

    Volume 4, Issue 4, October 2010, Pages: 215–221, Jae Woo Jung, Eun Ju Jeon, Jae Gyu Kim, Suh-Yoon Yang, Jae Chol Choi, Jong Wook Shin, In Won Park, Byoung Whui Choi, Don-Kyu Kim and Jae Yeol Kim

    Version of Record online : 9 DEC 2009, DOI: 10.1111/j.1752-699X.2009.00178.x

  10. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  11. You have free access to this content
    Population pharmacokinetic analysis of varenicline in adult smokers

    British Journal of Clinical Pharmacology

    Volume 68, Issue 5, November 2009, Pages: 669–681, Patanjali Ravva, Marc R. Gastonguay, Thomas G. Tensfeldt and Hélène M. Faessel

    Version of Record online : 7 AUG 2009, DOI: 10.1111/j.1365-2125.2009.03520.x

  12. You have free access to this content
    AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1834–1845, Andrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramirez, Roberto Ciccocioppo, Taline V Khroyan, Dennis Yasuda, Nurulain T Zaveri, Conrado Pascual, Xinmin (Simon) Xie and Lawrence Toll

    Version of Record online : 23 JAN 2015, DOI: 10.1111/bph.13034

  13. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Version of Record online : 25 JUN 2014, DOI: 10.1111/bph.12690

  14. Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis

    Addiction

    Volume 111, Issue 9, September 2016, Pages: 1554–1567, Qi Wu, Simon Gilbody, Emily Peckham, Sally Brabyn and Steve Parrott

    Version of Record online : 9 JUN 2016, DOI: 10.1111/add.13415

  15. Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 607–614, SL McColl, AH Burstein, KR Reeves, CB Billing Jr, M Stolar and EM Sellers

    Version of Record online : 20 FEB 2008, DOI: 10.1038/sj.clpt.6100510

  16. Use of stop-smoking medications in the United States before and after the introduction of varenicline

    Addiction

    Volume 110, Issue 2, February 2015, Pages: 346–355, Karin A. Kasza, K. Michael Cummings, Matthew J. Carpenter, Monica E. Cornelius, Andrew J. Hyland and Geoffrey T. Fong

    Version of Record online : 20 NOV 2014, DOI: 10.1111/add.12778

  17. Effects of Varenicline on Ethanol- and Food-Maintained Responding in a Concurrent Access Procedure

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 7, July 2013, Pages: 1228–1233, Brett C. Ginsburg and Richard J. Lamb

    Version of Record online : 15 FEB 2013, DOI: 10.1111/acer.12085

  18. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1086–1092, Mira Harrison-Woolrych, Helen Paterson and Ming Tan

    Version of Record online : 8 AUG 2013, DOI: 10.1002/pds.3489

  19. Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System

    Addiction

    Volume 108, Issue 1, January 2013, Pages: 203–210, Tamra E. Meyer, Lockwood G. Taylor, Suji Xie, David J. Graham, Andrew D. Mosholder, James R. Williams, David Moeny, Rita P. Ouellet-Hellstrom and Trinka S. Coster

    Version of Record online : 18 OCT 2012, DOI: 10.1111/j.1360-0443.2012.04024.x

  20. Relative Potency of Varenicline or Fluvoxamine to Reduce Responding for Ethanol Versus Food Depends on the Presence or Absence of Concurrently Earned Food

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 3, March 2014, Pages: 860–870, Brett C. Ginsburg and Richard J. Lamb

    Version of Record online : 29 OCT 2013, DOI: 10.1111/acer.12285